TD Cowen downgrades Novavax to Market Perform, PT $10.00

A TD Cowen analyst downgraded Novavax (NASDAQ: NVAX) from Outperform to Market Perform with a price target of $10.00 from a prior price target of %currency%%price%.
Prior to this rating, Novavax had 3 buy ratings, 1 hold ratings, and 2 sell ratings.
For consensus analyst estimates and price targets on Novavax, click here. For more news on Novavax, click here.
Novavax's stock price closed at $8.96. They are up 55.02% in the last month and down -81.64% in the last 12 months.
According to Investing Pro, Novavax's fair value is $10.71, an upside of 19.51%. Novavax's fair value comes with a high degree of uncertainty, according to InvestingPro.
Check out Novavax's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or